Related Experiment Video
Updated: Jun 26, 2026

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
[Postoperative serotonin syndrome in a patient with attention-deficit/hyperactivity disorder and treatment-resistant
Michael Nii Aboe Aboe1,2, Natalia Wege3
1Klinik und Poliklinik für Innere Medizin, Universitätsspital Zürich, Zürich.
Introduction:
A patient diagnosed with attention-deficit/hyperactivity disorder (ADHD) and treatment-resistant depression (TRD) developed postoperative serotonin syndrome after exposure to venlafaxine, opioids, stimulants, and cannabis. The Hunter criteria facilitated the diagnosis; discontinuation of serotonergic agents and supportive measures led to reversal.
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Drug Therapy
Antianxiety Medications
Antidepressant Drugs: Overview
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.